New insulin option shows promise for diabetes patients
NCT ID NCT04980027
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This study tested a long-acting insulin called Gla-300 in 228 adults with type 2 diabetes whose blood sugar was not well controlled by oral medications. Participants had never used insulin before. The main goal was to check safety, including side effects and low blood sugar events. The study also looked at how well the insulin controlled blood sugar and whether patients were more satisfied with their treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site Number 3560003
Jaipur, 302017, India
-
Investigational site Number 3560013
Nashik, 422002, India
Conditions
Explore the condition pages connected to this study.